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Abstract
Recent studies demonstrate that astroglial cells can be directly converted into functional
neurons or oligodendrocytes. Here, we report that a single transcription factor Sox10 could
reprogram astrocytes into oligodendrocyte-like cells, in vivo. For transdifferentiation, Sox10-
GFP expressing viral particles were injected into cuprizone-induced demyelinated mice
brains after which we assessed for the presence of specific oligodendrocyte lineage cell
markers by immunohistofluorescence (IHF). As control, another group of demyelinated
mice received GFP expressing viral particles. After 3 weeks, the majority of transduced
(GFP+) cells in animals which received control vector were astrocytes, while in animals
which received Sox10-GFP vector, the main population of GFP+ cells were positive for oli-
godendrocyte lineage markers. We also extracted primary astrocytes from mouse pups and
purified them. Primary astrocytes were transduced in vitro and then transplanted into
demyelinated brains for later fate mapping. After three weeks, in vitro transduced and then
transplanted astrocytes showed oligodendrocyte progenitor and mature oligodendrocyte
markers. Further confirmation was done by transduction of astrocytes with lentiviral particles
that expressed Sox10 and GFP and their culture in the oligodendrocyte progenitor medium.
The induced cells expressed oligodendrocyte progenitor cells (iOPCs) markers. Our find-
ings showed the feasibility of reprogramming of astrocytes into oligodendrocyte-like cells in
vivo, by using a single transcription factor, Sox10. This finding suggested a master regula-
tory role for Sox10 which enabled astrocytes to change their fate to OPC-like cells and
establish an oligodendroglial phenotype. We hope this approach lead to effective myelin
repair in patients suffering from myelination deficit.
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Introduction
Oligodendrocytes possess a pivotal role in ensheathing axons by myelin. Their pathology con-
tributes to various disorders including multiple sclerosis (MS), white matter stroke, traumatic
CNS injury, and age-related myelin loss. Replacing the oligodendrocytes is a promising
approach for therapeutic applications, in particular the generation of autologous sources of oli-
godendrocyte progenitor cells (OPCs) is of great interest.
In vivo conversion of somatic cells into desired cell types is considered a proper approach to
generate progenitor repair cells for therapeutic purposes with emphasis on organs that have a
low capacity to regenerate. In vivo lineage reprogramming approaches have been demon-
strated in the brain[1, 2], spinal cord [3], heart [4], and pancreas [5].
Astrocytes are the most plentiful cellular components of glial scars which develop following
neural cell loss from degenerative diseases and traumatic injuries by reactivation of astrocytes
and their secretions [6]. Previous studies demonstrated that astrocytes could be directly con-
verted into neurons or stem-like cells by the forced expression of transcription factors in vitro
[7–11], which highlights the capability of fate change of these somatic glial cells. Recently, sev-
eral attempts have been made to convert astrocytes within the brain parenchyma to neurons
by Sox2 [3, 12, 13], NeuroD1 [1], Ascl1 [14], and MicroRNA 302/367 [15]. In this strategy,
instead of surgical removal of the glial scar, reactive astrocytes are converted into progenitor
cells that contribute to tissue repair. Developmentally, astrocytes and oligodendrocytes are
produced from glial progenitors and may be considered as differentiated cells with similar epi-
genetic states [16]. In previous reports conversion of astrocytes to myelinating cells was done
using MicroRNA 302/367 and transcription factor Oct4 that were not specific to oligodendro-
cytes [17, 18]. The same MicroRNA also produced neuroblasts which had the capability to dif-
ferentiate into mature neuron-like cells in normal brains [15] and animal models of
neurodegeneration and Alzheimer’s disease [19, 20]. Therefore, in the current study, we
attempted to locate a single transcription factor specific to oligodendrocyte lineage cells that
had the capability for in vivo conversion of astrocytes into OPCs.
Sox10 is a transcription factor related to the sex determining region Y (SRY)-boxes gene
family expressed constantly throughout OPC development into mature oligodendrocytes[21].
Numerous evidences suggest that Sox10 is as a master regulator in the developmental process of
oligodendrocytes and activation of myelination genes [22–24]. This transcription factor in com-
bination with NKX6.2 and Olig2 [25]or Olig2 and ZFP536 [26] has the capability to reprogram
rodent fibroblasts into induced OPCs (iOPCs). Continuous expression of Sox10 in satellite cells
of dorsal root ganglion via a transgene approach has led to ectopic development of oligodendro-
cytes [27]. While NFIA is known as a key astrocyte fate determinant factor, it has been reported
that Sox10 suppresses astrocytic differentiation by an antagonistic relationship with NFIA and
regulating the oligodendrocyte and astrocyte fate during development [28] In fact, Sox10 posi-
tive astrocytes have been hardly detected in corpus callosum and brain cortices [29].This reports
also provide another explanation for using Sox10 to convert astrocytes to OPCs.
To the best of our knowledge, this is the first report of using forced expression of a myelina-
tion specific transcription factor, Sox10 that has induced astrocytes to reprogram into oligo-
dendrocyte lineage cells.
Materials and methods
Viral particle preparation
The desired construct containing a CDS for the Sox10 gene was generated by ligation between
a sox10 CDs (extracted from Tet-O-FUW-Sox10) and a pSSFV-IRES-GFP plasmid, to acquire
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the pSSFV-Sox10-IRES-GFP. Tet-O-FUW-Sox10 was a gift from Marius Wernig (Addgene
plasmid # 45843). The schematic diagram for vectors are presented in Panel A in S1 Fig.
Confluent human embryonic kidney cells (HEK 293T) were transfected with pSSFV-Sox10-
IRES-GFP or pSSFV-IRES-GFP constructs and packaging plasmids (pCMV-vsvg and pCMV-
gp) using Lipofectamine 3000 (Life Technologies). At 48 and 72 h post-transfection the cell
culture media was collected, filtered, and centrifuged to concentrate the viral particles. The col-
lected particles were re-suspended in 100 μL PBS for subsequent infections.
Induction of demyelination in animals
Male C57BL/6 mice, 7–8 weeks old, (Royan Institute) were housed in a climate-controlled
room with access to food and water ad libitum. All experiments were performed in accordance
with the international guide for the care and use of laboratory animals. The experimental pro-
cedures wereevaluated and approved by the Committee for Ethics in Animal Research at
Royan Institute. Attempts were made to minimize the number of animals used and their suf-
fering. For demyelination induction, mice were fed with 0.2% (w/w) oxalic acid bis(cyclohexy-
lidenehydrazide) (cuprizone; Sigma-Aldrich, C9012) mixed into their normal chow for 12
weeks. We conducted the Y-maze test and histological studies to confirm the presence of
behavioral impairment due to demyelination and extensive demyelination in their brains.
Spontaneous alternations within the Y-maze was tested prior to induction of demyelination
and after the 12-week period of cuprizone administration in their chow. The Y-maze arms
were marked A, B, and C. The number of overlapping entrance sequences (e.g., ABC, BCA)
was defined as the number of spontaneous alternations. We calculated the percent of alterna-
tions as follows [30].
Percent of alternations = (number of alternations)/ (total number of arm entries-2) ×100.
The number of total arm entries was calculated as the index of ambulatory activity in the Y-
maze. We excluded any animals with scores of less than six entries.
Animal interventions
We evaluated the possible conversion of transduced cells into myelinating cells. The schematic
diagram for animal interventions are presented in Panel B in S1 Fig. Mice with cuprizone
induced demyelination were anesthetized with ketamine (100 mg/kg, i.p., GE Healthcare, Ger-
many) and xylazine (5 mg/kg, i.p., Bayer, Germany), then placed in a stereotaxic frame in a flat
skull position. Lentiviral particles (2 μl of concentrated solution) were injected into each cor-
pus callosum at the following coordinates from the atlas of Paxinos and Watson: anteroposter-
ior (AP) = -1.06, mediolateral (ML) = 1 from the bregma, and dorsoventral (DV) = 1.5 mm
from the skull. Animals received a normal diet for 3 or 8 weeks after the injection.
We assessed the conversion of astrocytes to oligodendrocyte lineage cells by transducing
purified astrocytes (see below) with pSSFV-Sox10-IRES-GFP or pSSFV-IRES-GFP viruses.
After 48 h, we transplanted 1×105 cells into the corpora callosa of the mice with demyelinated
brains. The animals received immunosuppression by daily injections of cyclosporine A (20
mg/kg; Novartis Pharmaceuticals, East Hanover, NJ, USA) from 2 days before surgery until 3
weeks after transplantation.
Tissue sampling and immunohistofluorescence (IHF) studies
Animals were deeply anesthetized and perfused transcardially with saline, followed by 4%
paraformaldehyde (Sigma-Aldrich, P6148) prepared in PBS. Then, the brains were removed,
post-fixed overnight in 4% PFA, and cryoprotected for 48 h in 30% sucrose. Samples were
embedded in optimal cutting temperature (OCT) compound and serial 10 μm-thick coronal
Sox10 converted astrocytes to oligodendrocyte progenitors
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sections were cut using a cryostat (Leica Microsystems, CM 1850). The cut sections were
stored at -20˚C and then processed for immunohistofluorescence (IHF) analysis.
Sections were washed three times in PBS, then incubated in blocking solution that consisted
of 0.1% Triton X-100 (Sigma-Aldrich, T8532), 1% bovine serum albumin, and 5% normal
serum in PBS for 1 h at room temperature, followed by an overnight incubation with primary
antibodies against NG2, Olig2, glial fibrillary acidic protein (Gfap), PdgfRα, Plp, Mbp or
NeuN at 4˚C. Sections were washed three times with PBS and incubated at room temperature
for 2 h with the secondary antibody. List of antibodies is provided in S1 Table. After treatment
with 40, 6-diamidino-2-phenylindole (DAPI; Sigma-Aldrich; D-8417), the sections were again
washed three times with PBS. For myelin staining with FluoroMyelin, sections were incubated
with FluoroMyelin Red (Invitrogen F34652, 1/300) solution dissolved in PBS for 20 minutes at
room temperature. Sections were coverslipped and then Images were obtained on an Olympus
IX51 fluorescence microscope with a DP72 digital camera and analySIS LS Starter software
version 3.2.
Astrocyte isolation and culture
Astrocytes were isolated based on the procedure by Schildge et al. [31] with some modifica-
tions. After removal of the meninges, grey matter tissue from the cerebral cortexes of P3-P5
C57BL/6J mice was dissected and mechanically dissociated. The suspension was centrifuged
for 5 min at 1000 rpm, re-suspended, and plated in a medium that contained DMEM/F12
(Invitrogen), 3.5 mM glucose (Sigma), 10% fetal bovine serum (Gibco), and 1% penicillin/
streptomycin (Gibco). After 24 h, the contaminating oligodendrocyte precursor cells were
removed by vigorous manual agitation. One week later, cells were passaged using and plated
in fresh medium. The CD44+ cell population was purified from a primary culture of astrocytes
by incubation with anti-CD44 antibody (BD550538) followed by MACS selection (Miltenyi
Biotech, Germany). We confirmed the fate of extracted cells and the purity of the sorted astro-
cytes by immunocytofluorescence (S2 and S3 Figs).
Transduction of astrocytes in culture
Purified astrocytes were transduced with prepared viral particles and kept in astrocyte media
for an additional 48 h. Afterwards, transduced cells were seeded on 0.1 mg/ml poly-l-ornithine
(Sigma-Aldrich; P4707) and 10 μg/ml laminin (Sigma-Aldrich; L2020) for in vitro induction
or transplanted into animal brains for in vivo transdifferentiation. In culture, the induction
medium was permissive to oligodendrocyte fate acquisition and consisted of DMEM/F12
(Invitrogen) supplemented with N2 (Invitrogen), B27 without vitamin A (Invitrogen), 2 mM
Glutamax (Invitrogen), 200 ng/ml SHH (Royan Biotech), 20 ng/ml bFGF (Royan Biotech),
and 20 ng/ml PDGF-AA (Royan Biotech). Cultures were fixed after 21 days and stained against
the OPC markers, Olig2 and NG2, and neuronal marker Tuj1; after which we determined the
percent of transduced (GFP+) cells positive for NG2, Olig2 and Tuj1.
Data analysis
When required, we performed cell counts in several randomly selected views of all samples
from each brain section. At least 8 sections were counted per animal and each animal group
included 3 mice. For statistical comparison of the means of different groups, one-way
ANOVA followed by the Tukey post-test was used except for the Y-maze data which we com-
pared with the Wilcoxon signed-rank test for matched pairs. The results were expressed as
mean±SEM. A probability of p<0.05 was considered statistically significant.
Sox10 converted astrocytes to oligodendrocyte progenitors
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Results
Previous studies reported that a 12-week cuprizone diet led to extensive demyelination in the
mice brains. This finding was particularly noted in the corpus callosum of each brain.
Researchers have reported that a 12-week cuprizone diet decreased endogenous remyelination
[32, 33] and therefore provides an adequate model to study the capability of in situ induced
OPCs or transplanted cells for myelination. Astrogliosis, defined as astrocyte hypertrophy and
reactivity, is one of the most important features of this demyelination model [34]. Gfap stain-
ing showed extensive astrocyte reactivation within the brains (Fig 1A). FluoroMyelin staining
showed extensive corpus callosum demyelination in cuprizone-treated animals compared to
control mice of the same age (20 weeks; Fig 1B). Demyelination was also confirmed by luxol
fast blue staining (Fig 1C). Spatial working memory is affected following cuprizone induced
demyelination in mice [35]. Measurements of spontaneous alternations within the symmetric
Y maze confirmed the presence of myelination decline in the study mice. The treated mice
showed significant impairment in terms of total arm entries and spontaneous alternations
compared to baseline (Fig 1D and 1E).
We designed a construct to express GFP and Sox10 under the control of the same promoter
(pSSFV-Sox10-IRES-GFP) in order to detect the transduced cells (Panel A in S1 Fig) and
injected as viral particles into the corpora callosa of the mice after confirmation of demyelin-
ation using Y maze. In order to determine the identity of transduced cells, the pSFFV-IRES-
GFP lentiviral particles which label the transduced cells without changing their fate, were
injected into the corpora callosa (Panel B in S1 Fig). After 21 days, the animals were sacrificed
for brain sampling and IHF studies against different cell markers. Accordingly, most trans-
duced cells tested positive for Gfap as a marker of astrocytes (Fig 2A), while oligodendrocyte
lineage cells comprised a small number of transduced cells (Fig 2B–2D). There were no promi-
nent co-expressions of NeuN (a neuronal marker) and GFP detected, which indicated that the
neurons were not transduced. The lack of transduction appeared to be due to their distinct
location from the injection site (Fig 2E). Following quantification, the proportion of different
cell types within the transduced GFP+ cells were as follows: 72.75%±4.3 (Gfap+), 13.5%±1.8
(PdgfRα+), 15%±2.8 (NG2+), and 11.25%±1.3 (Olig2+). No NeuN+/ GFP+ cells were detected
(Fig 2F). A part of above mentioned cells may be originated from the transduced progenitor
cells which have been differentiated to astrocytes or oligodendroglial cells during 3 weeks
chase time. Therefore the origin of transduced cells in this experiment remains not fully
cleared.
We investigated whether Sox10 could convert astrocytes into oligodendrocyte lineage cells
in vivo. Viral particles that contained the pSFFV-Sox10-IRES-GFP (Sox10-GFP) vector were
directly delivered into the corpora callosa of the cuprizone induced demyelinated mice, where
reactive astrocytes persisted. Mice were followed for 3 weeks after the injection. Ultimately, the
brain samples were collected and prepared for sectioning and staining against astrocyte
marker Gfap (Fig 3A), and oligodendrocyte markers PdgfRα (Fig 3B), NG2 (Fig 3C), and
Olig2 (Fig 3D). Interestingly, as the representative micrographs showed, higher numbers of
GFP+/Olig2+, GFP+/NG2+, and GFP+/PdgfRα+ cells compared to GFP+/Gfap+ cells were
counted. Fig 3E shows the quantified data for the percentages of different GFP+ cell types.
Within the GFP+ cells, we observed significantly more Olig2+, NG2+, and PdgfRα+ cells com-
pared to Gfap+ cells (all: p<0.001). When compared the percentage of GFP+ cells with differ-
ent labels to those mentioned in Fig 2 (animals which received only-GFP expressing vector),
there was a significantly reduced number for Gfap+ cells (72.75% vs. 20%). The number of
GFP+ cells stained with oligodendrocyte lineage cell markers were significantly increased by
Sox10 converted astrocytes to oligodendrocyte progenitors
PLOS ONE | https://doi.org/10.1371/journal.pone.0203785 September 13, 2018 5 / 18
Fig 1. Confirmation of astrocyte reactivation and demyelination induction in mice brains treated with cuprizone. A) Immunohistofluorescence (IHF) staining for
glial fibrillary acidic protein (Gfap) in control animals. Extensive astrogliosis was observed after 12 weeks of cuprizone feeding as mentioned in A. The nuclei were
stained with DAPI. B) (FM) staining against myelin for the control (B) and cuprizone (B’) groups. C) Luxol fast blue (LFB) staining of myelin in control (C) and
cuprizone treated animals (C’) showed extensive demyelination. D, E) Memory performance of control and cuprizone-treated mice. Spontaneous alternations (D) and
number of total arm entries (E) was assessed using the Y-maze test. (n = 10). Horizontal lines show baseline amounts for each parameter. : p<0.05 compared to the
control groups (Wilcoxon matched-pairs signed rank test). LV: Lateral ventricle; CC: Corpus callosum. Scale bars: 200 μm.
https://doi.org/10.1371/journal.pone.0203785.g001
Sox10 converted astrocytes to oligodendrocyte progenitors
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Fig 2. Determining the fate of cells transduced with pSSFV-IRES-GFP lentiviral particles injected into the corpus callosum.
(A-E) Immunofluorescence staining against astrocytes marker Gfap, Oligodendrocyte lineage cell markers PdgfRα, NG2, Olig2 and
neuron marker (NeuN) at 3 weeks post injection (wpi) of pSSFV-IRES-GFP lentiviral particles into the corpora callosa of
demyelinated mice brains. Gfap+ astrocytes comprised the main population of transduced cells. (F) Quantified results for
immunostaining against different markers used in A-E. Data are presented as mean±S.E.M. : p<0.001, n = 3 mice per group.
Scale bar: 50 μm, n.d.: Non-detectable.
https://doi.org/10.1371/journal.pone.0203785.g002
Fig 3. Changes in the fate of cells transduced with SSFV-Sox10-IRES-GFP lentiviral viruses in vivo. (A) Immunohistofluorescence staining showed lower number of
GFP+ cell stained with Gfap. The expression of PdgfRα (B), NG2 (C), and Olig2 (D) markers in transduced cells within the corpus callosum, at 3 weeks post injection
(wpi) was increased. GFP+ cells mainly expressed Olig2, PdgfRα, and NG2 (right panels show higher magnifications). E) Quantified results for immunostaining against
different markers. Data are presented as mean±S.E.M. : p<0.001 compared to Gfap, n = 3 animals.
https://doi.org/10.1371/journal.pone.0203785.g003
Sox10 converted astrocytes to oligodendrocyte progenitors
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Sox10 expression, e.g. NG2+ cells increased from 15% to 74% which purpose possible conver-
sion of astrocytes to oligodendrocyte lineage cells.
In another group of animals, Sox10-GFP expressing viral vectors were injected into the cor-
pora callosa of demyelinated mice and the samples were collected 8 weeks after the injection.
Staining against Mbp and Plp as markers of mature oligodendrocytes showed that transduced
(GFP+) cells were mainly differentiated to oligodendrocytes-like cells (Fig 4A and 4B). Data
quantification showed that 70.66±2.6 and 62.25± 3.3 percent of GFP+ cells were respectively
Mbp+ and Plp+ (Fig 4C).
The previous experiment showed that local injection of Sox10-expressing vector into the
demyelinated corpus callosum increased the number of oligodendrocytes lineage-like cells
within the transduced cells. Since the origin of in vivo transduced cells was not fully clear, it
was not possible to make a solid conclusion that astrocytes had the capability to differentiate to
oligodendrocyte-like cells after receiving the Sox10 expression vector. Therefore, we planned
to extract primary astrocytes, purify and transduce them with Sox10 expressing vector for sub-
sequent transplantation into demyelinated mice corpora callosa. To prepare the starting cells,
we isolated astrocytes from the brains of 3–5 day-old mice (S2 Fig). The primary culture cells
underwent magnetic activated cell sorting against the CD44 cell surface marker to obtain a
pure population of astrocytes. Astrocytes were negative for NG2, Sox10 and Olig2 as OPC and
oligodendrocyte markers, and negative for Nestin as a marker for neural progenitors as evalu-
ated by immunocytofluorescence (S3 Fig). We transduced astrocytes in vitro and subsequently
transplanted them into the corpora callosa of the cuprizone-induced demyelinated brains (Fig
5A). After 3 weeks, the brain sections were stained for Gfap (astrocyte marker) and PdgfRα,
NG2, Mbp, and Plp as markers of oligodendrocyte progenitors and mature oligodendrocytes.
According to Fig 5B–5F, GFP+ cells expressed PdgfRα and NG2, as markers of OPCs, as well
as Mbp and Plp, as markers of myelinating oligodendrocytes. A low number of GFP+ cells
were still Gfap+. As we observed in 6 independent animals, following transplantation, GFP
only-transduced astrocytes could not survive at 3 weeks after transplantation. These data may
provide an evidence that Sox10 but not GFP (as control) caused in vivo trans-differentiation of
astrocytes to oligodendrocyte lineage cells which were capable to integrate into the tissue and
survive.
To further support the process of in vivo reprograming of astrocytes by sox10, astrocytes
were transduced in vitro by viral particles and subsequently cultured in OPC induction
medium (Fig 6A). Approximately during 16–21 days after induction, we observed morpholog-
ical changes in GFP-Sox10 vector transduced cells but not in GFP transduced astrocytes (Fig
6B–6D). Interestingly, in Sox10 treated cells, the large flat shape morphology shifted into bipo-
lar spindle-like cells (Fig 6C and 6D) with proliferation capacity in response to PDGF-AA,
bFGF and SHH. The induced cells showed expression of exogenous Sox10 as well as enhanced
expression of OPC markers including Olig2, Myrf and endogenous Sox10 as assessed using
RT-PCR. These cells did not express Krox20 a peripheral neural cell marker which showed the
lack of Schwan cell differentiation. Astrocytes transduced with GFP vector did not express oli-
godendrocytes markers (Panel A in S4 Fig). The expressions of exogenous and endogenous
Sox10 was measured using differentiating primers. Olig2 expression was increased during
days 5–9 post induction (Panel B in S4 Fig). Compared to GFP vector transduced astrocytes,
Fig 4. Expression of mature oligodendrocytes markers by in vivo transduced cells at 8 weeks post viral particles
injection. GFP+ cells were mainly positive for Mbp (A) and Plp (B). C) Quantification of results for immunostaining
against mature oligodendrocyte markers presented in A and B. Scale bars: 50 μm.
https://doi.org/10.1371/journal.pone.0203785.g004
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induced OPC-like cells showed decreased levels of Gfap and S100b expression (Panel C in S4
Fig).
Expressions of the OPC markers were confirmed at the protein level by ICF against NG2
and Olig2 (Fig 6E and 6F). Induced cells were negative for Tuj1 expression as a marker of neu-
rons (Fig 6G). Quantification of positive cells showed that 88.33%±2.1 of GFP positive cells
exposed to induction OPC medium were NG2+, 74.33%±1.2 were Olig2+ and no Tuj1+ cell
was detected (Fig 6H).
Discussion
Sox10 is related to the SRY gene family that regulates myelin gene expression in embryonic
and adult oligodendrogenesis [36]. This factor binds to the enhancer of genes important for
myelination, such as Myrf [37], Olig2 [27], and Mbp [38], and promotes oligodendrocyte
differentiation.
In situ conversion of reactive astrocytes present in the glial scars to progenitor cells such as
OPCs suggests a new attitude toward myelin repair by replacement of reduced oligodendro-
cytes. This strategy also enhances repair potential by reducing the inhibitory components of
glial scars. The outcomes of the current study have shown that astrocytes could possibly be
converted into oligodendrocyte lineage cells by ectopic expression of a single transcription fac-
tor, Sox10. This finding supported previous reports where Sox10 in accordance with two other
transcription factors reprogrammed rodent fibroblasts into iOPCs [25, 26]. Here, we used one
out of the three previously reported transcription factors. Astrocytes have been used as the
starting cells because they share a common embryonic origin with oligodendrocytes and con-
tain extensive similarities in their epigenomes. In this study, we choose a single gene. A report
showed the effectiveness of Sox10 to convert satellite glia into oligodendrocyte-like cells in the
peripheral nervous system [27]. Several studies have shown the plasticity of astrocytes to repro-
gram into iPSCs [39, 40], NSCs [11], neuroblasts [12], and mature neurons [10][14]. The reac-
tive astrocytes within active demyelinated lesions are hypertrophic and proliferative, with
some neural stem cell-like properties [6] that make them prone for reprogramming to progen-
itors. In addition, it has been reported that Sox10 can suppress astrocytic differentiation of
glial progenitors via antagonistic relationship with NFIA as a key astrocyte fate determinant
factor [28]. This may explain why Sox10 positive cells extracted from early post-natal brains
mainly differentiate to oligodendrocyte [29]. Therefore NFIA inhibition by Sox10 may provide
a possible mechanism for conversion of transduced astrocytes to oligodendrocyte lineage cells.
Here we have attempted to show the possible potency of Sox10 for in situ conversion of
reactive astrocytes to OPCs. We observed reactivation of astrocytes in the brains of mice
treated with cuprizone for 12 weeks. The viral particles were delivered to the corpora callosa of
mice in order to target the astrocytes. At 3 weeks after the injection, astrocytes comprised
72.75% of GFP+ cells that received GFP control vector which imply for the astrocyte fate of the
major group of transduced cells. Of course it should be mentioned that some labeled astrocytes
or oligodendroglial cells observed in this experiment might be originated from progenitor cells
Fig 5. In vivo conversion of purified mouse astrocytes transduced with SSFV-Sox10-IRES-GFP lentiviral particles after
transplantation into the corpora callosa of demyelinated mice brains. A) Schematic diagram of the experimental procedure of
demyelination induction, Y maze test for data presented in Fig 1D and 1E, astrocyte transduction, and transplantation. B)
Immunohistofluorescence (IHF) staining against Gfap showed the lack of notable co-expressions of GFP and Gfap as astrocyte
marker at 3 weeks post injection (wpi). C-D) Expressions of PdgfRα (C) and NG2 (D) markers in the main population of GFP
+ cells in the corpus callosum at 3 wpi. The bottom panels show higher magnifications. E-F) IHF showed that transplanted
astrocytes (GFP+) could express mature oligodendrocyte markers Mbp (E) and Plp (F) at 3 wpi. n = 3 animals, CysA: cyclosporine
A for preventing rejection of transplanted cells, Scale bars: 50 μm.
https://doi.org/10.1371/journal.pone.0203785.g005
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transduced by GFP expressing viral vector at the time of viral particles injection. Most GFP
+ cells that received Sox10 expressing vector expressed OPC markers Olig2 (73.75%), PdgfRα
(54%), and NG2 (74%). Therefore a shift from astrocytes to OPCs by Sox10 was possibly
occurred. At 8 weeks after the injection, some of the transduced cells expressed Mbp and Plp,
as markers of mature oligodendrocytes. While the expression of ectopic Sox10 contributed to
the conversion of transduced cells to OPCs, the role of the internal microenvironment of the
demyelinated lesion should not be overlooked. Our previous experiments showed that in vivo
ectopic expression of MicroRNA 302/376 in astrocytes converted them to neuroblasts [15],
whereas application of the same microRNA into the brains of cuprizone fed mice caused trans-
differentiation of astrocytes to oligodendrocyte lineage cells [17] which indicate the determin-
ing role of microenvironment.
The enhanced number of OPCs 3 weeks after injection of the viral particles might be due to
the conversion of astrocytes to OPCs; but other possibilities including proliferation of trans-
duced OPCs and death of transduced astrocytes, or possible transduction of neural progenitors
and their subsequent differentiation to OPCs by Sox10 might be plausible. Therefore, in order
to prove conversion of astrocytes to OPCs, we extracted and purified astrocytes from the cor-
texes of P3-P5 mice. After transduction with viral particles that expressed GFP or GFP/Sox10,
we transplanted the cells to the demyelinated mice brains and traced the transplanted cells at 3
weeks after transplantation. Results showed that transplanted cells expressed oligodendrocyte
lineage cell markers, but in low amounts the astrocyte marker. Because of the very local con-
version of astrocytes to oligodendrocytes within the injection site it was not expected that the
transdifferentiated cells improve the animal behavior in Y-maze, while myelin staining for
transplanted cells was observed. To support the proof of concept for the conversion of astro-
cytes to an oligodendrocyte lineage by Sox10, we attempted to show the possible potency of
Sox10 for in vitro conversion of cultured astrocytes to OPCs. Our findings demonstrated that
ectopic expression of Sox10 in astrocytes led to the expression of endogenous Sox10, Myrf and
Olig2 in vitro. Expression of these key transcription factors was accompanied with supporting
morphological changes.
In this study we used a continuous active promoter to express Sox10, however the endoge-
nous Sox10 and Olig2 locus became active in induced OPC-like cells as shown in S4 Fig;
accordingly converted cells might be a stable lineage independent on the transgene. The con-
trols, the GFP vector-transduced cells in the oligodendrocyte media, lacked the ability to trans-
differentiate to OPC-like cells which showed a pivotal role for Sox10. Sox10 function highly
depends on its expression level [41]. However, we were unable to manage the exact copy num-
ber of ectopic genes expressed in each cell. This might explain why a population of infected
cells were not converted to oligodendrocyte lineage.
Ultimately, our proof-of-principle study may suggest the achievability of in vivo astrocyte
conversion into oligodendrocyte-like cells using Sox10 gene delivery into the demyelinated
Fig 6. Changes in morphological marker proteins expression during generation of Sox10-induced oligodendrocyte
progenitor-like cells (OPCs) from astrocytes and Characterization of induced OPCs. A) Schematic time diagram and the
content of culture medium for in vitro generation of induced oligodendrocyte progenitor cells (iOPCs) from astrocytes via
Sox10 expression. B, B´) Typical morphology of control astrocytes which were transduced with IRES-GFP vector. C, C´)
Morphology of Sox10-transduced cells preserved in OPC induction medium for 21 (21 dpi). (D, D´) Magnified images of the
white square in C, C´ which shows a bipolar morphology for induced cells. E-G) Immunofluorescence images of
Sox10-IRES-GFP induced oligodendrocyte progenitor cells (iOPCs) stained with OPC markers NG2 (E) and Olig2 (F), and
neuron marker Tuj1 (G) at 21 day post induction. In vitro induction of astrocytes to OPCs was repeated 3 times. Non-
transduced cells in E and F (blue nuclei) did not express OPC markers. G) Quantification of NG2+, Olig2+ and Tuj1+ cells as
percent of GFP+ cells. Cells were counterstained with DAPI. Scale bars: 50 μm.
https://doi.org/10.1371/journal.pone.0203785.g006
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lesions. Our data are promising for finding a new approach for myelin repair and astrocyte
removal in patients with demyelinating insults.
Supporting information
S1 Fig. Schematic diagram of the expression vectors used in this study as well as the experi-
mental procedure. A) The expression vector contained open reading frame sequences of
mouse Sox10 and GFP under the control of a single promoter, SSFV. Control vector did not
include Sox10 sequence. B) Schematic diagram of the experimental procedure for inducing
demyelination, Y maze test for data presented in Fig 1D and 1E, virus injection, and tissue
sampling.
(TIF)
S2 Fig. The morphology and characterization of isolated astrocytes before sorting. A)
immunocytofluorescence (ICF) showed that isolated astrocytes were positive for the glial
fibrillary acidic protein (Gfap). We observed few Nestin (B), NG2 (C) and Olig2 (D) positive
cells in cultured primary astrocytes. Scale bars: 100 μm.
(TIF)
S3 Fig. Determining the purity of sorted astrocytes. After sorting the astrocytes using anti-
CD44 antibody, we checked the purity of sorted astrocytes by immunocytofluorescence (ICF).
ICF showed that purified cells were positive for glial fibrillary acidic protein (Gfap) (A) and
negative for neural stem cell marker, Nestin (B), oligodendrocyte lineage markers Olig2 (C),
Sox10 (D) and NG2 (E). Scale bars: 50 μm.
(TIF)
S4 Fig. Induction of astrocytes to oligodendrocytes by exogenous Sox10 led to the expres-
sions of endogenous OPC markers. A) Agarose gel electrophoresis analysis at day 21 after
transduction confirmed the expression of endogenous Sox10, Olig2 and Myrf in cells trans-
duced with Sox10-GFP vector, but not in astrocytes transduced with GFP vectors. B) Olig2
expression was increased in induced cells during days 5–9. C) Expression of Gfap and S100b
as markers of astrocytes were reduced in induced OPC-like cells. Data in B and C was obtained
using RT-qPCR. Primer specifications are provided in S2 Table.
(TIF)
S1 Table. List of primary and secondary antibodies used in this study.
(DOCX)
S2 Table. Primer sets used for RT-qPCR analysis.
(DOCX)
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